about
Structural and mutational analysis of a monomeric and dimeric form of a single domain antibody with implications for protein misfoldingEvolving landscape in the management of transthyretin amyloidosisAmyloidogenic regions and interaction surfaces overlap in globular proteins related to conformational diseases.Structural typing of systemic amyloidoses by luminescent-conjugated polymer spectroscopy.The Open AUC Project.Cardiac amyloidosis responding to bortezomib: case report and review of literature.First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ DysfunctionHead and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis.A rare case of chronic diarrhea.A dilemma solved.Primary systemic amyloidosis presenting as idiopathic inflammatory colitisThe spectrum of kidney involvement in lymphoma: a case report and review of the literaturePrimary systemic amyloidosis as a real diagnostic challenge - case study.Current perspectives on cardiac amyloidosis.Factors associated with an increased risk of vertebral fracture in monoclonal gammopathies of undetermined significance.Effect of single point mutations in a form of systemic amyloidosis.Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium.A Tongue Lesion as a Sign of a Systemic DiseaseOutcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation.Amyloidosis in Alzheimer's Disease: The Toxicity of Amyloid Beta (A β ), Mechanisms of Its Accumulation and Implications of Medicinal Plants for TherapyFebrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis: a 'melphalan recall' reactionA model of amyloid's role in disease based on fibril fracture.Renal failure in multiple myeloma: a medical emergency.Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physicians.Recent advances in the diagnosis and management of cardiac amyloidosis.Future directions in the clinical management of amyloid light-chain amyloidosis.Natural polyphenols binding to amyloid: a broad class of compounds to treat different human amyloid diseases.Right ventricular cardiomyopathies: a multidisciplinary approach to diagnosis.Light Chain (AL) Amyloidosis: The Journey to Diagnosis.Mining databases for protein aggregation: a review.Disease burden of systemic light-chain amyloidosis: a systematic literature review.Formation of assemblies on cell membranes by secreted proteins: molecular studies of free λ light chain aggregates found on the surface of myeloma cells.Secondary systemic amyloidosis in inflammatory bowel disease: a nationwide analysis.Echocardiographic features of an atypical presentation of rapidly progressive cardiac amyloidosis.Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction.Effect of amino acid mutations on the conformational dynamics of amyloidogenic immunoglobulin light-chains: A combined NMR and in silico study.Ultrasound-guided percutaneous renal biopsy-induced accessory renal artery bleeding in an amyloidosis patientAn unusual presentation and etiology of hypotension seen in nephrotic syndrome.Amyloidosis involving the respiratory system: 5-year's experience of a multi-disciplinary group's activity
P2860
Q27694789-C7609F2A-76C1-474D-8C0B-442894FACE5FQ28086773-EC896A8A-52DD-48B4-92A3-1444E02225D3Q33495551-930CD0C3-7218-41C7-8E0E-045943CE5990Q33597057-428220A8-B454-41A4-BC18-FBA99897C8FEQ33615915-2409A5F7-8F5E-4E3C-BE1D-57A1C9477F3FQ33654026-AE4AEF57-E65B-4F82-AD4E-0508E05CA951Q33795363-03784E16-8A27-4615-B62D-C42AA2304258Q34007478-F19869C5-AAF2-49E0-8F19-7FD5A352FB5AQ34353682-858AFD22-2ADE-4182-85C1-43DD75769032Q34378523-9A38A777-0B9F-45A0-8DDF-9DCB8B799EA0Q34522518-25D5CABA-F089-4A73-954A-1FCDB7AD7C2EQ35296249-2B436306-D492-4FDB-AE90-B2E30F1F951CQ35567531-2A9EFBBB-78E9-4049-88F0-0267565026FEQ35631725-E52C9614-D90F-4034-84C6-CE30DEDCE1C5Q35964900-1D5E1D74-E2E7-412C-9AB2-3DE26F048205Q36022586-874E97FC-5DE1-42B3-A301-1FB25045C0ACQ36061556-096DD4B5-7700-4925-94EA-9CC1F8118C26Q36254199-62B33751-C8AE-4CDA-B1D3-16E847CDCEA6Q36764579-903A0793-77D2-4915-8309-CCA16DE8B729Q36779777-B8700D86-8281-4690-ADDA-E8BABFC927AEQ36898656-AEDB70F5-ED57-4EDF-BC70-F445BA9A064BQ36901282-362F3575-ABDD-479D-A279-818E88AEAB11Q37389184-D507644A-5618-4819-829F-19F6303F4D75Q37845643-7B89FD2E-835A-4960-BE92-C15CA99EF7EFQ38114487-6DD9198D-4B07-436C-BCC6-BD32CD3C8D4DQ38171831-4F8B3525-953E-4DEF-87BF-ADE2EAEA7B3EQ38172998-AE56E821-18F7-43C7-8AC7-4435F68BD8FCQ38244247-F3372717-5E8F-4B38-A32C-98CBEEBDA5F6Q38252394-9266BEF9-7A2C-4977-A9B6-290CAFA69E4EQ38556941-9317D174-6C24-4052-A66D-CD8717157250Q38673966-58E414A4-19B9-43AD-874B-CB533518DCDEQ38917828-414CD4BF-AF5E-475E-9394-633BC72E4945Q39131174-7AA5E3D1-2AB0-4B52-B128-0C104B53C806Q40078209-DF5D84E8-C598-4A1A-B14A-7E8A88DA2133Q41001742-B508F9F2-8B6A-48EE-9199-2DF61B71E16DQ41106725-4EB2C13C-1BC3-4F29-B187-1D3279BC3244Q41606174-99711A04-A61F-48C9-AAC0-53A8712968FAQ41848685-A2614086-19C8-4A63-845B-35C1225F0B63Q41875307-56BAE051-94D3-4B4C-9C41-AD7DCC2C8306Q42095765-CD7DD43F-B71D-4D19-BCE7-DCA599DA66AA
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Light-chain (AL) amyloidosis: diagnosis and treatment.
@ast
Light-chain (AL) amyloidosis: diagnosis and treatment.
@en
type
label
Light-chain (AL) amyloidosis: diagnosis and treatment.
@ast
Light-chain (AL) amyloidosis: diagnosis and treatment.
@en
prefLabel
Light-chain (AL) amyloidosis: diagnosis and treatment.
@ast
Light-chain (AL) amyloidosis: diagnosis and treatment.
@en
P356
P1476
Light-chain (AL) amyloidosis: diagnosis and treatment.
@en
P2093
Vaishali Sanchorawala
P304
P356
10.2215/CJN.02740806
P577
2006-10-11T00:00:00Z